Samsrita labs has announced its strategic expansion into the Pet Animal Healthcare and Wellness segment, marking a significant diversification move for the healthcare company. The expansion falls within the scope of the existing Object Clause of the company's Memorandum of Association and was disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Strategic Expansion Details

The company's expansion into pet healthcare represents a natural extension of its existing human healthcare expertise. SAMSrita LABS LIMITED aims to leverage its rigorous healthcare standards to provide high-quality, professional grooming and therapeutic services in the pet wellness space.

Market Rationale and Growth Drivers

The expansion is supported by compelling market fundamentals in India's pet care ecosystem. The company has identified several key factors driving this strategic decision:

• Market Growth: The Indian pet care market is experiencing robust CAGR of over 20%
• Economic Drivers: Rising disposable incomes and urban demographics fuel market expansion
• Consumer Behavior Shift: The "Pet Humanization" trend transforms pet services from discretionary luxury to essential wellness category
• Strategic Synergy: Application of healthcare expertise to pet wellness creates competitive advantage

Market Positioning and Value Creation

SAMSrita LABS LIMITED believes this strategic expansion will create long-term value for shareholders by accessing a high-growth, high-margin consumer segment. The pet humanization trend has fundamentally changed how pet owners view grooming and spa services, elevating these offerings from optional luxuries to essential wellness requirements.

The company's approach involves applying its established healthcare standards to the pet wellness market, potentially creating a differentiated service offering in the rapidly evolving pet care landscape.

Corporate Disclosure

The announcement was made through a formal disclosure dated 11-03-2026, signed by K. Krishnam Raju, Chairman & Whole-time Director. The disclosure ensures compliance with regulatory requirements while informing stakeholders of the company's strategic direction and growth initiatives.

Samsrita Labs Limited has completed the mandatory newspaper publication of its unaudited financial results for the third quarter of FY26, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company reported a substantial widening of losses for the quarter, with net loss reaching ₹335.56 lakhs compared to ₹4.05 lakhs in the corresponding quarter of the previous year.

Regulatory Compliance and Publication

The company published its financial results in Financial Express (English newspaper) and Nava Telangana (Telugu newspaper) on February 7, 2026. The publication included QR codes and webpage details where complete unaudited standalone and consolidated financial results are accessible to investors.

Financial Performance Overview

The healthcare sector company's financial performance was significantly impacted by a major asset write-off during the quarter ended December 31, 2025. The primary driver of the increased losses was a significant write-off of intangible assets under development worth ₹3,25,95,369.

Nine-Month Performance

The nine-month period ended December 31, 2025, showed similarly concerning trends with net loss reaching ₹856.72 lakhs compared to ₹17.25 lakhs in the previous year. The company's paid-up equity share capital stood at ₹2,274.97 lakhs as of December 31, 2025, compared to ₹1,480.87 lakhs in the previous year.

Asset Write-off Impact

The company stated that the intangible asset write-off was necessitated by technological obsolescence, as the underlying patents are no longer expected to provide future economic benefits. This write-off was recognized in the Statement of Profit and Loss for the quarter and represents a substantial one-time charge affecting the company's financial performance.

Board Approval and Accessibility

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 6, 2026. The complete results are available on stock exchange websites ( www.bseindia.com and www.msei.in ) and the company's webpage, accessible through QR codes published in the newspapers. The results have been prepared in accordance with Indian Accounting Standards (Ind AS) and have undergone limited review by statutory auditors.